Therapeutic Peptides

Therapeutic Peptides, Inc. (TPI) is a biotechnology company based in Baton Rouge, Louisiana, specializing in the discovery, development, and manufacture of performance-enhancing peptides for the skincare and personal healthcare industries. Founded in 1992 by Dr. Don R. Owen, the company maintains an extensive library of proprietary lipo-oligopeptides used in anti-aging, antimicrobial, and anti-inflammatory applications. TPI provides custom peptide synthesis and formulation services, often collaborating with its affiliate, Owen Biosciences, Inc., to bring advanced dermatological products to market. The company is recognized for its innovation in "green" peptide manufacturing, including the production of TFA-free peptides. In 2008, the global fragrance and flavor leader Symrise AG acquired a 20% stake in TPI to secure distribution rights for its innovative cosmetic ingredients. TPI's products, such as the antimicrobial peptide Chelasyn, are utilized by various skincare brands to address indications like acne, wrinkles, and skin repair.